Articles by Gill A. Webster, PhD - BioPharm International

Articles by Gill A. Webster, PhD

The Therapeutic Vaccine Potential of MIS416 Adjuvant

Linking innate and adaptive immunity through the activation of multiple innate host defenses.
Jan 2, 2009
By: Gill A. Webster, PhD, Frank B. Gelder, PhD

This article discusses the potential of MIS416 adjuvant, a vaccine adjuvant and immunogen co-delivery system, to provide adequate immunostimulation to overcome host factors that may limit the success of therapeutic vaccines.